| Mr Enola Nashoba Hastiin, | |
|
524 Kenora Dr, Millersville, MD 21108-1317 | |
| (706) 945-9776 | |
| Not Available |
| Full Name | Mr Enola Nashoba Hastiin |
|---|---|
| Gender | Male |
| Speciality | Counselor - Mental Health |
| Location | 524 Kenora Dr, Millersville, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114449386 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Enola Nashoba Hastiin, 524 Kenora Dr, Millersville, MD 21108-1317 Ph: (706) 945-9776 | Mr Enola Nashoba Hastiin, 524 Kenora Dr, Millersville, MD 21108-1317 Ph: (706) 945-9776 |
News Archive
PATH and Quansys Biosciences, Inc. have announced the launch of a new diagnostic tool designed to help researchers develop more sensitive and reliable malaria rapid diagnostic tests and to support public health surveillance.
Morgan Advanced Materials has announced plans to launch its own range of standard brazed filament supports, complementing its existing portfolio of high-specification products.
For the first time, a strategic plan for research into benign prostate disease, based on the latest scientific knowledge, has been published by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH). The NIDDK Prostate Research Strategic Plan is the culmination of discussions and meetings among experts over the past two years in an effort to outline a strategic vision for research into these elusive and multi-faceted diseases.
New technologies have been likened, famously, to magic. At first, even the few who understand how they work have a tendency to sit back and marvel. Soon, flaws and limitations are detected and the invention process begins again, resulting, almost always, in improvements.
PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH) today noted the European Commission (EC) approval of Merck & Co., Inc.'s ELONVA®, a long-acting CTP-modified version of the fertility drug follicle stimulating hormone (FSH).
› Verified 4 days ago
Mrs. Lisa Ann Maher, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1111 Benfield Blvd Ste 200, Millersville, MD 21108 Phone: 667-600-2494 | |
Lawrence G Iacarino, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1110 Benfield Blvd, Suite H, Millersville, MD 21108 Phone: 410-987-3448 Fax: 410-987-4710 | |
Brooke Schetgen, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 8258 Veterans Hwy, Suite 13, Millersville, MD 21108 Phone: 410-768-6088 Fax: 410-768-6444 | |
Luvenia M Simmons, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 8258 Veterans Hwy Ste 13, Millersville, MD 21108 Phone: 410-768-6088 Fax: 410-768-6444 | |
Mrs. Rebecca Wrotny, LCSW-C, CSAC Counselor Medicare: Accepting Medicare Assignments Practice Location: 1111 Benfield Blvd Ste 104, Millersville, MD 21108 Phone: 667-600-2494 Fax: 410-729-8496 | |
Jessica Marie Lindsay, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 8258 Veterans Hwy, Suite 13, Millersville, MD 21108 Phone: 410-768-6088 | |
Corry J Bulkley, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 8258 Veterans Hwy, Suite 13, Millersville, MD 21108 Phone: 410-768-6088 Fax: 410-768-6444 |